Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion type Assertion NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_head.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion description "[PF00299804 is a highly effective inhibitor of both the wild-type ERBB2 and the gefitinib-resistant oncogenic ERBB2 mutation identified in lung cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_provenance.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion evidence source_evidence_literature NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_provenance.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion SIO_000772 18089823 NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_provenance.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion wasDerivedFrom lhgdn-20090331 NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_provenance.
- NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_assertion wasGeneratedBy ECO_0000203 NP161219.RAaoSmHNgRg7TwuLI7G0AOQUVVe8AlhDZnDUePvWis0s4130_provenance.